Quarterly report pursuant to Section 13 or 15(d)

Segments - Narrative (Details)

v3.5.0.2
Segments - Narrative (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2016
Customer
Sep. 30, 2015
Sep. 30, 2016
USD ($)
Segment
Customer
Sep. 30, 2015
Dec. 31, 2015
Customer
Segment Reporting Information [Line Items]          
Number of reportable segments | Segment     2    
Customer Concentration Risk | Sales Revenue, Net          
Segment Reporting Information [Line Items]          
Number of customer represented | Customer 0   0    
Customer Concentration Risk | Accounts Receivable          
Segment Reporting Information [Line Items]          
Number of customer represented | Customer     0   1
Intersegment Elimination          
Segment Reporting Information [Line Items]          
Inter-segment sales | $     $ 0    
Inter-segment allocation of interest expense | $     $ 0    
Pfizer | Customer Concentration Risk | Sales Revenue, Net          
Segment Reporting Information [Line Items]          
Percentage of product revenue contributed by customer   12.00%   22.00%